Clinical trial
Prevention of Coronavirus Disease (COVID-19) Outbreaks by Prophylactic Treatment With Nitazoxanide
NCT04406246 is registered in ClinicalTrials.gov with Materno-Perinatal Hospital of the State of Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Coronavirus Disease (COVID-19) Outbreaks by Prophylactic Treatment With Nitazoxanide
- Lead sponsor
- Materno-Perinatal Hospital of the State of Mexico
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 21, 2020
- Completion date
- December 31, 2020
- Enrollment
- 150 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronavirus infection